Sector consensus Bio-Rad Laboratories, Inc. NYSE

Stocks

Market Closed - NYSE 04:10:00 2026-08-20 pm EDT			5-day change	1st Jan Change
365.08 ^USD	+8.33%		+8.33%	+17.50%

Aug. 07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
Aug. 05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' target price evolution (4 months)	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
BIO-RAD LABORATORIES, INC.	-	-	-	-	-	-	-
ABBOTT LABORATORIES					120.2	+3.5%	25
MEDTRONIC PLC					97.92	+7.44%	25
CENCORA, INC.					369.31	+12.57%	13
HOYA CORPORATION					30,620	+22.5%	15
BECTON, DICKINSON AND COMPANY					194.42	+2.44%	12
DEXCOM, INC.					94.12	+5.56%	25
MEDLINE INC.					44.62	+25.18%	26
WEST PHARMACEUTICAL SERVICES, INC.					404.73	+16.14%	15
TERUMO CORPORATION					3,133.08	+20.67%	13
STERIS PLC					263.12	+11.29%	8
SARTORIUS STEDIM BIOTECH					232.64	+19.73%	14
ZIMMER BIOMET HOLDINGS, INC.					107.57	+7.31%	21
SOLVENTUM CORPORATION					93.92	+2.52%	13
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED					42.95	-4.35%	11
BAXTER INTERNATIONAL INC.					28.73	+9.27%	11
ALIGN TECHNOLOGY, INC.					208.6	+30.69%	15
GLOBUS MEDICAL, INC.					103.23	+24.43%	13
REPLIGEN CORPORATION					185.7	+2.21%	20
BIO-RAD LABORATORIES, INC.					329	-15.71%	5
Average					1,930.2	+10.71%	16
Weighted average by Cap.					2,387.04	+9.26%	19